Titan Medical to Host Business Update Conference Call on February 6, 2018
January 30 2018 - 12:11PM
Titan Medical Inc. (“Titan” or the “Company”)
(TSX:TMD) (OTCQB:TITXF), a medical device company focused on the
design, development and commercialization of a robotic surgical
system for application in minimally invasive surgery (“MIS”),
announces that management will host a conference call on Tuesday,
February 6, 2018 at 4:30 p.m. ET to provide a business update on
Titan Medical’s SPORT Surgical System. Ricardo Estape, M.D.,
renowned robotic gynecologic oncology surgeon with South Miami
Gynecology Oncology Group, will participate in the call and provide
thoughts on his experience with Titan’s SPORT single port system in
validation studies conducted at the Florida Hospital Nicholson
Center, one of the Company’s three centers of excellence.
To access the conference call, the dial-in
numbers are (866) 595-8403 (U.S. and Canada toll free), and (706)
758-9979 (International). All listeners should provide the operator
with the following conference ID: 6886519.
Following the conclusion of the conference call,
a replay will be available through February 12, 2018 and can be
accessed by dialing (855) 859-2056 (U.S. and Canada toll free), and
(404) 537-3406 (International). All listeners should provide the
operator with the following conference ID: 6886519. The call will
also be archived on the Company’s website for a period of time at
www.titanmedicalinc.com.
About Titan Medical Inc.
Titan Medical Inc. is a Canadian public company
focused on research and development through to the planned
commercialization of computer-assisted robotic surgical
technologies for application in minimally invasive surgery. The
Company is currently developing the SPORT Surgical System, a
single-port robotic surgical system. The SPORT Surgical System is
comprised of a surgeon-controlled patient cart that includes a 3D
high definition vision system and multi-articulating instruments
for performing MIS procedures, and a surgeon workstation that
provides the surgeon with an advanced ergonomic interface to the
patient cart and a 3D endoscopic view inside the patient’s body
during MIS procedures. With the SPORT Surgical System, the Company
aims to pursue a broad set of surgical indications, including
general abdominal, gynecologic and urologic procedures.
For more information, please visit the Company’s
website at www.titanmedicalinc.com.
Contacts:
LHA Investor RelationsKim Sutton Golodetz(212)
838-3777kgolodetz@lhai.com orBruce Voss(310)
691-7100bvoss@lhai.com
Titan Medical (TSX:TMD)
Historical Stock Chart
From Apr 2024 to May 2024
Titan Medical (TSX:TMD)
Historical Stock Chart
From May 2023 to May 2024